[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100581561":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":15,"centralContacts":7,"locations":19,"responsibleParty":45,"collaborators":7,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":7,"eligibilityCriteria":54,"healthyVolunteers":50,"sex":55,"minAge":56,"maxAge":7,"enrollmentInfo":57,"targetDuration":7,"studyType":60,"phases":7,"briefSummary":61,"conditions":62,"keywords":64,"overallStatus":22,"whyStopped":7,"lastUpdateSubmitDate":69,"lastUpdatePostDateStruct":70,"startDateStruct":73,"completionDateStruct":75,"leadSponsor":77,"locationsCount":78},{"fullName":5,"class":6},"Hospital Universitari de Bellvitge","OTHER",null,[9],{"type":10,"name":11,"description":12,"armGroupLabels":7,"otherNames":13},"DRUG","Lacosamide","Patients will be included if they are prescribed intravenous lacosamide for their trigeminal neuralgia exacerbation",[14],"Vimpat",[16],{"name":17,"affiliation":5,"role":18},"Albert Muñoz Vendrell, PhD","PRINCIPAL_INVESTIGATOR",[20],{"facility":21,"status":22,"city":23,"state":24,"zip":25,"country":26,"countryCode":27,"cosmosGeoPoint":28,"geoPoint":33,"contacts":34},"Hospital de Bellvitge","RECRUITING","L'Hospitalet de Llobregat","Barcelona","08907","Spain","ES",{"type":29,"coordinates":30},"Point",[31,32],2.10028,41.35967,{"lat":32,"lon":31},[35,39,40,43],{"name":17,"role":36,"phone":37,"phoneExt":7,"email":38},"CONTACT","+34932607412","unitatcefalea@bellvitgehospital.cat",{"name":17,"role":18,"phone":7,"phoneExt":7,"email":7},{"name":41,"role":42,"phone":7,"phoneExt":7,"email":7},"Mariano Huerta Villanueva, PhD","SUB_INVESTIGATOR",{"name":44,"role":42,"phone":7,"phoneExt":7,"email":7},"Sergio Campoy, MD",{"type":18,"investigatorFullName":46,"investigatorTitle":47,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Albert Muñoz Vendrell","Principal Investigator","100581561","intravenous-lacosamide-for-the-treatment-of-acute-pain-in-trigeminal-neuralgia-100581561",false,"NCT06851910","Intravenous Lacosamide for the Treatment of Acute Pain in Trigeminal Neuralgia","Intravenous Lacosamide for the Treatment of Acute Pain in Trigeminal Neuralgia: A Prospective Observational Study","All patients diagnosed with trigeminal neuralgia who present to the emergency department of Hospital de Bellvitge for an acute pain exacerbation and are prescribed intravenous lacosamide as symptomatic pain treatment, according to the treating physician's discretion, will be considered for inclusion.\n\nInclusion Criteria:\n\n* Diagnosis of classical or idiopathic trigeminal neuralgia according to the criteria of the International Classification of Headache Disorders (ICHD-3).\n* Age over 18 years.\n* Signed informed consent.\n\nExclusion Criteria:\n\n* Contraindication for treatment with lacosamide (previous hypersensitivity reaction, known atrioventricular block).\n* Mental or psychiatric illness that interferes with the ability to understand and sign the informed consent.\n* Language barrier.\n* Lack of cooperation.","ALL","18 Years",{"count":58,"type":59},20,"ESTIMATED","OBSERVATIONAL","This prospective observational study evaluates the effectiveness and safety of intravenous lacosamide as a rescue treatment for acute pain in patients presenting to the emergency department with trigeminal neuralgia",[63],"Trigeminal Neuralgia",[65,66,67,68],"trigeminal neuralgia","lacosamide","acute treatment","rescue treatment","2025-04-27",{"date":71,"type":72},"2025-04-29","ACTUAL",{"date":74,"type":72},"2025-04-21",{"date":76,"type":59},"2027-05",{"name":5,"class":6},1]